SPOTLIGHT -
WVE-004 Treatment for C9orf72 ALS and FTD: Merit Cudkowicz, MD
The director of the Sean M. Healey & AMG Center for ALS outlined the trial, which will evaluate ideal dose level and frequency of the investigational treatment for patients with C9-ALS and C9-FTD.
Merit Cudkowicz, MD, MSc: Assessing NurOwn in ALS
The director of the Healey & AMG Center for ALS spoke to the recent topline results of a phase 3 study of NurOwn in patients with the neuromuscular disease.
